WALTHAM, Mass., Dec. 01, 2022 (Globe NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a scientific-stage biopharmaceutical enterprise focused on the growth of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the therapy of sufferers with cancer, today introduced it has been named 1 of the Major Locations to Work in Massachusetts in the 15th yearly personnel-centered study undertaking from The Boston World. The Prime Sites to Operate 2022 was released online at Globe.com/TopPlaces and will show up in the World Journal on Sunday, December 4, 2022. TScan ranks as the top midsize biotechnology enterprise, and 8th out of the top rated fifty midsize companies overall in the Leading Areas to Perform in Massachusetts in the 15th yearly employee-based survey venture.
Prime Sites to Work recognizes the most admired workplaces in the state voted on by the men and women who know them ideal – their staff members. The survey actions personnel viewpoints about their company’s route, execution, link, management, function, spend and advantages, and engagement. The companies are put into just one of four groups: compact, with 50-99 staff members medium, with 100 to 249 personnel significant, with 250 to 999 and largest, with 1,000 or more.
“The staff at TScan is driven by impressive science and the mission to superior the lives of sufferers and their families to ensure that far more birthdays and significant lifetime times are celebrated,” reported David P. Southwell, President and Main Government Officer. “As we attempt to make that mission a fact, we are also committed to the welfare of our personnel, and we at TScan are all committed to creating a culture that supports us all when we use ourselves to the significant operate we do. I extend a honest thank you to our group of TScanners who work so diligently toward strengthening the lives of people and families impacted by cancer, while also producing a earth-class lifestyle of which to be very pleased.”
“The lifestyle we have designed at TScan is intricately connected to our values and mission, and just about every TScanner is an integral section of sustaining this energetic and collaborative natural environment,” mentioned Ann Hargraves, Vice President of Human Means. “We are proud to obtain this recognition, which we perspective as a testament to the solid, worker-centered, inclusive, and pushed corporation we have fostered, even as TScan has found large progress.”
TScan is dedicated to the discovery of new most cancers targets and the enhancement of safe and sound and powerful T cell therapies by unleashing the untapped potential of the human immune procedure.
The rankings in Prime Locations to Function are based on confidential survey data collected by Energage (previously WorkplaceDynamics), an unbiased enterprise specializing in staff engagement and retention, from far more than 90,000 folks at 381 Massachusetts companies. The winners share a handful of essential characteristics, which includes presenting additional overall flexibility to carry on doing work remotely, monitoring progress on attempts to support a varied workforce, and, higher than all, remembering to have some pleasurable along the way.
Best Locations to Work online extras include sortable rankings and characteristics these kinds of as showcasing companies that are going the additional mile to make their workplaces additional equitable and to assistance workers link with just one an additional, and their communities, for the duration of the pandemic. All can be uncovered at Globe.com/TopPlaces. Visitors can follow the information on Twitter at #workboston.
About TScan Therapeutics, Inc.
TScan is a clinical-stage biopharmaceutical organization focused on the growth of T cell receptor (TCR)-engineered T mobile therapies (TCR-T) for the treatment of individuals with cancer. The Company’s direct TCR-T remedy candidates, TSC-100 and TSC-101, are in enhancement for the remedy of sufferers with hematologic malignancies to eliminate residual illness and protect against relapse just after allogeneic hematopoietic cell transplantation. The Business is also building multiplexed TCR-T remedy candidates for the cure of numerous good tumors. The Organization has created and continues to establish its ImmunoBank, the Company’s repository of therapeutic TCRs that recognize diverse targets and are connected with a number of HLA types, in get to deliver customized multiplexed TCR-T therapies for patients with a wide range of stable tumors.
About Boston World Media Companions, LLC
Boston World Media Associates, LLC (“BGMP”) is a multimedia group that supplies information, amusement, and commentary across various brands and platforms. BGMP offers top built-in promoting methods that join communities, suggestions, and leads to through potent storytelling and multimedia ordeals. BGMP attributes incorporate The Boston Globe, Globe Impression, Globe.com, Boston.com, STAT, The B-Side, World Publishing Products and services, Globe Activities, and Studio/B.
TScan Therapeutics, Inc.
VP, Trader Relations
LifeSci Advisors, LLC